vs
Side-by-side financial comparison of HEALTHY CHOICE WELLNESS CORP. (HCWC) and Invivyd, Inc. (IVVD). Click either name above to swap in a different company.
HEALTHY CHOICE WELLNESS CORP. is the larger business by last-quarter revenue ($18.7M vs $17.2M, roughly 1.1× Invivyd, Inc.). HEALTHY CHOICE WELLNESS CORP. runs the higher net margin — -8.9% vs -64.3%, a 55.5% gap on every dollar of revenue.
Invivyd, Inc. is a clinical-stage biopharmaceutical company focused on developing broadly neutralizing antibody therapies to prevent and treat serious viral infectious diseases. Its core research and development pipeline targets high-burden respiratory pathogens including respiratory syncytial virus, catering to unmet medical needs of global patient groups.
HCWC vs IVVD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $18.7M | $17.2M |
| Net Profit | $-1.7M | $-11.1M |
| Gross Margin | 39.1% | — |
| Operating Margin | -7.6% | -73.0% |
| Net Margin | -8.9% | -64.3% |
| Revenue YoY | — | 24.5% |
| Net Profit YoY | — | 40.0% |
| EPS (diluted) | $-0.05 | $0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $18.7M | $17.2M | ||
| Q3 25 | $19.0M | $13.1M | ||
| Q2 25 | $20.2M | $11.8M | ||
| Q1 25 | $20.3M | $11.3M | ||
| Q4 24 | — | $13.8M | ||
| Q3 24 | $18.2M | $9.3M | ||
| Q2 24 | — | $2.3M | ||
| Q1 24 | — | $0 |
| Q4 25 | $-1.7M | $-11.1M | ||
| Q3 25 | $-1.2M | $-10.5M | ||
| Q2 25 | $-339.4K | $-14.7M | ||
| Q1 25 | $-712.4K | $-16.3M | ||
| Q4 24 | — | $-18.4M | ||
| Q3 24 | $-2.7M | $-60.7M | ||
| Q2 24 | — | $-47.2M | ||
| Q1 24 | — | $-43.5M |
| Q4 25 | 39.1% | — | ||
| Q3 25 | 38.8% | — | ||
| Q2 25 | 40.1% | — | ||
| Q1 25 | 38.8% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 38.4% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -7.6% | -73.0% | ||
| Q3 25 | -3.2% | -84.0% | ||
| Q2 25 | -0.2% | -127.8% | ||
| Q1 25 | -2.0% | -149.7% | ||
| Q4 24 | — | -139.1% | ||
| Q3 24 | -2.0% | -670.0% | ||
| Q2 24 | — | -2175.2% | ||
| Q1 24 | — | — |
| Q4 25 | -8.9% | -64.3% | ||
| Q3 25 | -6.4% | -79.7% | ||
| Q2 25 | -1.7% | -124.4% | ||
| Q1 25 | -3.5% | -144.1% | ||
| Q4 24 | — | -133.5% | ||
| Q3 24 | -14.6% | -653.1% | ||
| Q2 24 | — | -2086.9% | ||
| Q1 24 | — | — |
| Q4 25 | $-0.05 | $0.02 | ||
| Q3 25 | $-0.09 | $-0.06 | ||
| Q2 25 | $-0.03 | $-0.12 | ||
| Q1 25 | $-0.07 | $-0.14 | ||
| Q4 24 | — | $-0.14 | ||
| Q3 24 | $-0.29 | $-0.51 | ||
| Q2 24 | — | $-0.40 | ||
| Q1 24 | — | $-0.38 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.0M | $226.7M |
| Total DebtLower is stronger | $7.3M | — |
| Stockholders' EquityBook value | $7.3M | $241.5M |
| Total Assets | $33.5M | $276.9M |
| Debt / EquityLower = less leverage | 1.00× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.0M | $226.7M | ||
| Q3 25 | $3.0M | $85.0M | ||
| Q2 25 | $4.7M | $34.9M | ||
| Q1 25 | $1.8M | $48.1M | ||
| Q4 24 | — | $69.3M | ||
| Q3 24 | $1.8M | $106.9M | ||
| Q2 24 | — | $147.9M | ||
| Q1 24 | — | $189.4M |
| Q4 25 | $7.3M | — | ||
| Q3 25 | $8.5M | — | ||
| Q2 25 | $9.7M | — | ||
| Q1 25 | $10.6M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $11.6M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $7.3M | $241.5M | ||
| Q3 25 | $5.9M | $93.1M | ||
| Q2 25 | $5.8M | $42.8M | ||
| Q1 25 | $2.1M | $54.1M | ||
| Q4 24 | — | $67.5M | ||
| Q3 24 | $2.9M | $83.2M | ||
| Q2 24 | — | $140.6M | ||
| Q1 24 | — | $178.5M |
| Q4 25 | $33.5M | $276.9M | ||
| Q3 25 | $33.7M | $139.2M | ||
| Q2 25 | $36.4M | $89.1M | ||
| Q1 25 | $34.1M | $103.7M | ||
| Q4 24 | — | $129.5M | ||
| Q3 24 | $33.2M | $161.9M | ||
| Q2 24 | — | $177.3M | ||
| Q1 24 | — | $215.5M |
| Q4 25 | 1.00× | — | ||
| Q3 25 | 1.43× | — | ||
| Q2 25 | 1.69× | — | ||
| Q1 25 | 5.01× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 3.95× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $-855.1K | $-15.5M |
| Free Cash FlowOCF − Capex | $-927.1K | — |
| FCF MarginFCF / Revenue | -5.0% | — |
| Capex IntensityCapex / Revenue | 0.4% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $675.4K | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-855.1K | $-15.5M | ||
| Q3 25 | $-308.7K | $-8.3M | ||
| Q2 25 | $1.1M | $-13.3M | ||
| Q1 25 | $1.1M | $-21.1M | ||
| Q4 24 | — | $-37.6M | ||
| Q3 24 | — | $-41.1M | ||
| Q2 24 | — | $-41.6M | ||
| Q1 24 | — | $-50.2M |
| Q4 25 | $-927.1K | — | ||
| Q3 25 | $-351.3K | — | ||
| Q2 25 | $988.6K | $-13.3M | ||
| Q1 25 | $965.3K | $-21.3M | ||
| Q4 24 | — | $-37.6M | ||
| Q3 24 | — | $-41.1M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $-50.4M |
| Q4 25 | -5.0% | — | ||
| Q3 25 | -1.8% | — | ||
| Q2 25 | 4.9% | -112.9% | ||
| Q1 25 | 4.8% | -188.2% | ||
| Q4 24 | — | -272.2% | ||
| Q3 24 | — | -441.6% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | 0.4% | 0.0% | ||
| Q3 25 | 0.2% | 0.0% | ||
| Q2 25 | 0.4% | 0.1% | ||
| Q1 25 | 0.6% | 1.3% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.1% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HCWC
| Retail Grocery | $17.1M | 91% |
| Food Service Restaurant | $1.7M | 9% |
IVVD
Segment breakdown not available.